TherapeuticsMD (TXMD) Research & Development (2011 - 2022)
TherapeuticsMD's (TXMD) quarterly Research & Development came in at $1.1 million in Q3 2022, down 30.72% YoY from $1.6 million in Q3 2021, and down 29.62% on a QoQ basis from $1.6 million in Q2 2022.
TherapeuticsMD (TXMD) Research & Development (2011 - 2022) Analysis & Trends
TherapeuticsMD (TXMD) has 12 years of Research & Development data on file, last reported at $1.1 million in Q3 2022.
- Quarterly Research & Development fell 30.72% year-over-year to $1.1 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $23.0 million (down 72.54% YoY) and the FY2021 annual result came in at $7.1 million, down 93.95% from the prior year.
- Research & Development slipped to $1.1 million in Q3 2022, from $1.6 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $98.9 million in Q4 2019 to a low of $1.1 million in Q3 2022.
- A 5-year average of $13.5 million and a median of $6.3 million in 2019 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2019 — Research & Development surged 1364.06% — and 2022, when it tumbled 95.09%.
- Tracing TXMD's Research & Development over 5 years: stood at $6.8 million in 2018, then surged by 1364.06% to $98.9 million in 2019, then plunged by 73.71% to $26.0 million in 2020, then sank by 94.54% to $1.4 million in 2021, then dropped by 21.69% to $1.1 million in 2022.
- The last three Research & Development figures came in at $1.1 million (Q3 2022), $1.6 million (Q2 2022), and $18.9 million (Q1 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1.11 Mn |
| Jun 30, 2022 | 1.58 Mn |
| Mar 31, 2022 | 18.90 Mn |
| Dec 31, 2021 | 1.42 Mn |
| Sep 30, 2021 | 1.61 Mn |
| Jun 30, 2021 | 32.16 Mn |
| Mar 31, 2021 | 24.02 Mn |
| Dec 31, 2020 | 26.00 Mn |
| Sep 30, 2020 | 2.03 Mn |
| Jun 30, 2020 | 2.74 Mn |
| Mar 31, 2020 | 3.27 Mn |
| Dec 31, 2019 | 98.87 Mn |
| Sep 30, 2019 | 4.08 Mn |
| Jun 30, 2019 | 4.96 Mn |
| Mar 31, 2019 | 6.32 Mn |
| Dec 31, 2018 | 6.75 Mn |
| Sep 30, 2018 | 6.71 Mn |
| Jun 30, 2018 | 6.80 Mn |
| Mar 31, 2018 | 7.04 Mn |
| Dec 31, 2017 | 10.97 Mn |